Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.2%

10 terminated/withdrawn out of 82 trials

Success Rate

86.1%

-0.4% vs industry average

Late-Stage Pipeline

6 trials in Phase 3/4

Results Transparency

42%

26 of 62 completed trials have results

Key Signals

3 recruiting26 with results5 withdrawn

Enrollment Performance

Analytics

N/A

47(75.8%)

Phase 2

7(11.3%)

Phase 4

6(9.7%)

Phase 1

2(3.2%)

62Total

N/A(47)

Phase 2(7)

Phase 4(6)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (82)

Showing 20 of 82 trials

NCT06626516Phase 1Recruiting

Tebentafusp-tebn With LDT in Metastatic UM

Role: collaborator

NCT05626491Not ApplicableActive Not Recruiting

Electrical Stimulation for the Treatment of Glaucoma

Role: collaborator

NCT04639635Suspended

CNGB1 and Allied Disorders

Role: collaborator

NCT01425944Active Not Recruiting

Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

Role: collaborator

NCT04784234Not ApplicableTerminated

Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

Role: lead

NCT03675412Not ApplicableRecruiting

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Role: lead

NCT05325996Not ApplicableCompleted

Evaluating Home Testing Devices for the Management of Glaucoma

Role: lead

NCT00286637Recruiting

Novel Glaucoma Diagnostics

Role: lead

NCT05660447Phase 2Active Not Recruiting

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Role: lead

NCT06130384Phase 4Completed

Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Role: lead

NCT02982629Not ApplicableCompleted

Improving Access to Eye Care in Glaucoma Patients

Role: lead

NCT02347670Not ApplicableCompleted

Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population

Role: lead

NCT02390245Not ApplicableCompleted

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Role: lead

NCT03804684Not ApplicableCompleted

visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry

Role: lead

NCT03584958Unknown

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Role: lead

NCT04202510Not ApplicableWithdrawn

IOP and Medication Reduction in MIGS Procedures

Role: lead

NCT03323164Phase 4Completed

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Role: lead

NCT04459949Not ApplicableUnknown

Comparative Study of Sharkskin Versus Grieshaber Forceps During ILM Peeling

Role: lead

NCT03034772Phase 2Completed

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Role: lead

NCT02495935Not ApplicableUnknown

Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia

Role: lead